WATERS CORP /DE/ (WAT)
Laboratory Analytical Instruments · Laboratory Analytical Instruments · NYSE
$415.84
+3.64%
Investingg Score
53.5 / 100
Hold
Business overview
- Revenue growth YoY of 7%
- Gross margin of 59.3%
- Operating margin of 25.4%
These figures indicate solid top‑line growth and strong profitability margins, suggesting good business quality.
Financial health
- Market capitalization of $24.76 billion
- Free cash flow yield of 2.2%
The large market cap and modest free cash flow generation point to decent financial health, though cash yield is limited.
- Gross Margin
- 59.3%
- Operating Margin
- 25.4%
- Current Ratio
- 1.7x
- Debt / Equity
- 0.37
- Free Cash Flow (TTM)
- $0.5B
- Interest Coverage
- 12x
Valuation
- Trailing P/E ratio of 409.36
- Forward P/E ratio of 26.19
- EV/EBITDA of 85.13
- Price/sales ratio of 5.7
Current valuation is extremely high on a trailing basis, with forward metrics still elevated, creating uncertainty about price justification.
- P/E (TTM)
- 409.4x
- Forward P/E
- 26.2x
- Price / Sales
- 5.7x
- EV / EBITDA
- 85.1x
- FCF Yield
- 2.2%
Key risks
- Extremely high trailing P/E ratio
- Forward valuation still elevated
- Revenue growth may slow
Market cap $24.8B · data as of 2026-08-20
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze WAT with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.